VG Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	2005 - 2009
Period Ending	Sep '15 Sep 30, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	2005 - 2009
Revenue	-	-	-	-	-	0.01	Upgrade
Gross Profit	-	-	-	-	-	0.01	Upgrade
Selling, General & Admin	2.37	3.28	3.1	2.1	3.21	2.08	Upgrade
Research & Development	0.35	0.87	0.81	0.5	0.74	0.5	Upgrade
Operating Expenses	2.73	4.14	3.91	2.6	4.07	2.67	Upgrade
Operating Income	-2.73	-4.14	-3.91	-2.6	-4.07	-2.66	Upgrade
Interest Expense	-2.06	-2.76	-1.08	-3.76	-1.43	-2.91	Upgrade
Other Non Operating Income (Expenses)	0.46	0.68	-2.5	-0.58	-	-0	Upgrade
EBT Excluding Unusual Items	-4.33	-6.22	-7.48	-6.94	-5.49	-5.57	Upgrade
Legal Settlements	-	-	-	-	-	-1.67	Upgrade
Pretax Income	-4.33	-6.22	-7.48	-6.94	-5.49	-7.24	Upgrade
Earnings From Continuing Operations	-4.33	-6.22	-7.48	-6.94	-5.49	-7.24	Upgrade
Minority Interest in Earnings	0.03	0.03	0.06	0.09	0.07	-	Upgrade
Net Income	-4.3	-6.19	-7.42	-6.85	-5.42	-7.24	Upgrade
Net Income to Common	-4.3	-6.19	-7.42	-6.85	-5.42	-7.24	Upgrade
Shares Outstanding (Basic)	60	28	8	2	1	1	Upgrade
Shares Outstanding (Diluted)	60	28	8	2	1	1	Upgrade
Shares Change (YoY)	182.22%	237.41%	281.51%	74.57%	32.71%	58.03%	Upgrade
EPS (Basic)	-0.07	-0.22	-0.91	-3.19	-4.41	-7.81	Upgrade
EPS (Diluted)	-0.07	-0.22	-0.91	-3.19	-4.41	-7.81	Upgrade
Free Cash Flow	-0.86	-1.91	-1.04	-0.96	-1.02	-1.01	Upgrade
Free Cash Flow Per Share	-0.01	-0.07	-0.13	-0.45	-0.83	-1.09	Upgrade
Gross Margin	-	-	-	-	-	100.00%	Upgrade
Operating Margin	-	-	-	-	-	-46860.00%	Upgrade
Profit Margin	-	-	-	-	-	-127539.78%	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-17808.00%	Upgrade
EBITDA	-	-	-	-	-3.94	-2.59	Upgrade
D&A For EBITDA	-	-	-	-	0.12	0.07	Upgrade
EBIT	-2.73	-4.14	-3.91	-2.6	-4.07	-2.66	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.